OKUR · TickerCove

OKUROnKure Therapeutics, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $2.88 · now $2.88 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, OKUR has typically landed between $1.87 and $4.02 — a range of −35.2% to +39.7% from the issuance price $2.88.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,345 overlapping 1 month windows · 2021-04-08 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($2.88) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$2.88 · 19% of range

$2.32 low$5.27 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−3.5%

typical move · IQR 28.4%

−35.2%worst (p90)+39.7%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where OKUR has typically landed a month from the 2026-09-16 close of $2.88 — the range is history, not a prediction.

now $2.88 (+0.0%)
typical $2.78 (-3.5%)
middle 50% $2.37–$3.19
90% range $1.87–$4.02

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,345 windows spanning 2021-04-08 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2023-11-17	−80.2%	−80.2%	+14.6%
2023-12-13	−78.6%	−82.7%	+0.0%
2023-11-15	−78.4%	−78.5%	+17.2%
3 best
2023-02-21	+116.2%	−0.7%	+116.2%
2023-02-17	+106.0%	−1.7%	+106.0%
2023-02-15	+103.9%	+0.0%	+103.9%

1,345 overlapping windows · 2021-04-08 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

40%

−9.2%

n=5

Feb

60%

−4.9%

n=5

Mar

60%

+19.2%

n=5

Apr

60%

+7.1%

n=5

May

17%

−13.7%

n=6

Jun

33%

−0.5%

n=6

Jul

33%

+3.1%

n=6

Aug

33%

+3.0%

n=6

Sep

50%

−0.9%

n=6

Oct

80%

+5.1%

n=5

Nov

20%

−15.3%

n=5

Dec

40%

−18.8%

n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-06-22	Leverone Jason A.	officer	Sale	303 @ $4.40	$1K	−1.6% of holding	−3.1%	not yet — horizon still open	18,802	Form 4 · filed 2 days after the trade
2026-06-22	Saccomano Nicholas A	director	Sale	86 @ $4.40	$378	−0.8% of holding	−3.1%	not yet — horizon still open	11,247	Form 4 · filed 2 days after the trade
2026-03-23	Leverone Jason A.	officer	Sale	301 @ $4.16	$1K	−1.8% of holding	+17.4%	not yet — horizon still open	16,000	Form 4 · filed 1 day after the trade
2026-03-23	Saccomano Nicholas A	director	Sale	86 @ $4.16	$357	−1.2% of holding	+17.4%	not yet — horizon still open	7,333	Form 4 · filed 1 day after the trade
2025-12-22	Leverone Jason A.	officer	Sale	302 @ $2.97	$896	−1.8% of holding	−1.7%	+34.8%	16,301	Form 4 · filed 1 day after the trade
2025-12-22	Saccomano Nicholas A	director	Sale	87 @ $2.97	$258	−1.2% of holding	−1.7%	+34.8%	7,419	Form 4 · filed 1 day after the trade
2025-09-22	Leverone Jason A.	officer	Sale	303 @ $2.62	$795	−2.3% of holding	+14.3%	+54.0%	12,603	Form 4 · filed 2 days after the trade
2025-09-22	Saccomano Nicholas A	director	Sale	88 @ $2.62	$231	−2.4% of holding	+14.3%	+54.0%	3,506	Form 4 · filed 2 days after the trade
2025-06-23	Leverone Jason A.	officer	Sale	303 @ $2.38	$722	−2.3% of holding	−6.9%	+10.8%	12,906	Form 4 · filed 2 days after the trade
2025-06-23	Saccomano Nicholas A	director	Sale	88 @ $2.38	$210	−2.4% of holding	−6.9%	+10.8%	3,594	Form 4 · filed 2 days after the trade
2025-05-15	Cormorant Asset Management, LP	other	Sale	1,813,439 @ $1.85	$3.4M	−100.0% of holding	+24.1%	+38.0%	0	Form 4 · filed 4 days after the trade
2025-05-15	ACORN BIOVENTURES, L.P.	tenPercentOwner	Purchase	1,129,730 @ $1.85	$2.1M	ownership Δ n/a	+24.1%	+38.0%	1,129,730	Form 4 · filed 4 days after the trade
2025-05-15	ACORN BIOVENTURES, L.P.	tenPercentOwner	Purchase	270,270 @ $1.85	$500K	+18.8% of holding	+24.1%	+38.0%	1,709,944	Form 4 · filed 4 days after the trade
2025-05-12	Cormorant Asset Management, LP	other	Sale	24,300 @ $1.99	$48K	−1.3% of holding	+42.0%	+39.9%	1,813,439	Form 4 · filed 2 days after the trade
2025-04-07	Leverone Jason A.	officer	Sale	1,844 @ $2.67	$5K	−12.3% of holding	−41.7%	−36.7%	13,209	Form 4 · filed 1 day after the trade
2025-04-07	Saccomano Nicholas A	director	Sale	516 @ $2.67	$1K	−12.3% of holding	−41.7%	−36.7%	3,682	Form 4 · filed 1 day after the trade
2025-04-04	Leverone Jason A.	officer	Sale	1,278 @ $3.33	$4K	−7.8% of holding	−39.3%	−43.6%	15,053	Form 4 · filed 4 days after the trade
2025-04-04	Saccomano Nicholas A	director	Sale	358 @ $3.33	$1K	−7.9% of holding	−39.3%	−43.6%	4,198	Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

136 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-07	Carruthers R Michael	director	Award / grant	22,350	22,350	Form 4
2026-08-07	Agresta Samuel	officer	Award / grant	50,000	50,000	Form 4
2026-08-07	GREY MICHAEL G	director	Award / grant	22,350	22,350	Form 4
2026-08-07	Mathers Edward T	director	Award / grant	22,350	22,350	Form 4
2026-08-07	Ratcliffe Liam	director	Award / grant	22,350	22,350	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	150,000	150,000	Form 4
2026-08-07	Jansen Valerie Malyvanh	director	Award / grant	22,350	22,350	Form 4
2026-08-07	Leverone Jason A.	officer	Award / grant	50,000	50,000	Form 4
2026-08-07	Hartley Dylan	officer	Award / grant	50,000	50,000	Form 4
2026-08-07	Phillips Andrew John	director	Award / grant	22,350	22,350	Form 4
2026-08-07	Manke Isaac	director	Award / grant	300,000	300,000	Form 4
2026-08-07	Leverone Jason A.	officer	Disposition	130,611	0	Form 4
2026-08-07	Leverone Jason A.	officer	Award / grant	130,611	130,611	Form 4
2026-08-07	Manke Isaac	director	Disposition	15,300	0	Form 4
2026-08-07	Manke Isaac	director	Award / grant	15,300	15,300	Form 4
2026-08-07	Saccomano Nicholas A	director	Disposition	2,359	0	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	2,359	2,359	Form 4
2026-08-07	Saccomano Nicholas A	director	Disposition	1,485	0	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	1,485	1,485	Form 4
2026-08-07	Saccomano Nicholas A	director	Disposition	8,449	0	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	8,449	8,449	Form 4
2026-08-07	Saccomano Nicholas A	director	Disposition	16,898	0	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	16,898	16,898	Form 4
2026-08-07	Saccomano Nicholas A	director	Disposition	542,232	0	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	542,232	542,232	Form 4
2026-08-07	Manke Isaac	director	Disposition	15,300	0	Form 4
2026-08-07	Manke Isaac	director	Award / grant	15,300	15,300	Form 4
2026-08-07	Leverone Jason A.	officer	Disposition	5,781	0	Form 4
2026-08-07	Leverone Jason A.	officer	Award / grant	5,781	5,781	Form 4
2026-08-07	Leverone Jason A.	officer	Award / grant	5,322	5,322	Form 4
2026-08-07	Leverone Jason A.	officer	Disposition	130,611	0	Form 4
2026-08-07	Leverone Jason A.	officer	Award / grant	130,611	130,611	Form 4
2026-08-07	Agresta Samuel	officer	Disposition	18,588	0	Form 4
2026-08-07	Agresta Samuel	officer	Award / grant	18,588	18,588	Form 4
2026-08-07	Agresta Samuel	officer	Disposition	131,396	0	Form 4
2026-08-07	Agresta Samuel	officer	Award / grant	131,396	131,396	Form 4
2026-08-07	Hartley Dylan	officer	Disposition	137,603	0	Form 4
2026-08-07	Hartley Dylan	officer	Award / grant	137,603	137,603	Form 4
2026-08-07	Saccomano Nicholas A	director	Disposition	2,359	0	Form 4
2026-08-07	Saccomano Nicholas A	director	Award / grant	2,359	2,359	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i